comparison of two local anaesthetics in supraclavicular brachial plexus block in forearm and hand surgeries .

To compare 0.5% ropivacaine and 0.5% bupivacaine in supraclavicular brachial plexus block in upper limb surgery.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012750

Enrollment

Registered

2018-03-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- 60 patients of either sex of ASA class 1 or 2 posted for upper limb surgery under supraclavicular brachial plexus block

Interventions

Intervention1: Drug: 0.5% ropivacaine versus 0.5% bupivacaine in upper limb surgery under supraclavicular brachial plexus block Control Intervention1: 0.5% Ropivacaine: 0.5% Bupivacaine Control Interv

Eligibility

Inclusion criteria

Inclusion criteria: 60 patients of either sex of ASA class 1 or 2

Exclusion criteria

Exclusion criteria: History of respiratory ,cardiac ,hepatic or renal disease,pregnant women, any history of bleeding disorders,local infection at the site of injection,patient sensitive or allergic to bupivacaine or ropivacaine.

Design outcomes

Primary

Measure	Time frame
Mean duration of onset of sensory and motor block Mean Duration of analgesiaTimepoint: single	—

Secondary

Measure	Time frame
quality of anaesthesia between two groups. Any side effects of ropivacaine and bupivacaineTimepoint: Single	—

Countries

India

Contacts

Public ContactDrBalwinderjit walia

Panjab institute of medical sciences jalandhar

drbalwinder2000@yahoo.co.in9814087951

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026